hoe 33342 and Carcinoma, Non-Small Cell Lung

hoe 33342 has been researched along with Carcinoma, Non-Small Cell Lung in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Galluzzi, L; Kepp, O; Kroemer, G; Müller, K; Sauvat, A; Segura, F; Spaggiari, S; Wang, Y; Zhou, H1
Choi, JY; Han, JY; Kim, JY; Park, IH1
Chiba, M; Fujiwara, M; Goya, T; Kishino, T; Matsushima, S; Morii, T; Ogura, W; Ohnishi, H; Ohtsuka, K; Watanabe, T1
Cheng, T; Chuang, TS; Liao, D; Luo, Y; Markowitz, D; Reisfeld, RA; Shi, Q; Xiang, R; Zhou, H1

Other Studies

4 other study(ies) available for hoe 33342 and Carcinoma, Non-Small Cell Lung

ArticleYear
Quantification of cellular viability by automated microscopy and flow cytometry.
    Oncotarget, 2015, Apr-20, Volume: 6, Issue:11

    Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Benzimidazoles; Carbocyanines; Carcinoma, Non-Small-Cell Lung; Caspases; Cell Line, Tumor; Cell Membrane Permeability; Cell Survival; Connexins; Drug Synergism; Flow Cytometry; Fluorescent Dyes; High-Throughput Screening Assays; Humans; Indoles; Lung Neoplasms; Membrane Potential, Mitochondrial; Microscopy, Fluorescence; Nerve Tissue Proteins; Organoplatinum Compounds; Oxaliplatin; Robotics; Staining and Labeling; Staurosporine; Workflow

2015
Simvastatin enhances irinotecan-induced apoptosis in human non-small cell lung cancer cells by inhibition of proteasome activity.
    Investigational new drugs, 2011, Volume: 29, Issue:5

    Topics: Apoptosis; Benzimidazoles; Blotting, Western; Camptothecin; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Drug Screening Assays, Antitumor; Drug Synergism; Flow Cytometry; Humans; I-kappa B Proteins; Irinotecan; Lung Neoplasms; NF-kappa B; NF-KappaB Inhibitor alpha; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Simvastatin; Staining and Labeling; Substrate Specificity

2011
Downregulated ABCG2 enhances sensitivity to topoisomerase I inhibitor in epidermal growth factor receptor tyrosine kinase inhibitor-resistant non-small cell lung cancer.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2010, Volume: 5, Issue:11

    Topics: Adenocarcinoma; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzimidazoles; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; DNA Topoisomerases, Type I; DNA, Neoplasm; Down-Regulation; Drug Resistance, Neoplasm; Enzyme Inhibitors; ErbB Receptors; Genotype; Humans; Lung Neoplasms; Mutation; Neoplasm Proteins; Polymerase Chain Reaction; Protein Tyrosine Phosphatases; Quinazolines; Radiation-Sensitizing Agents; Tumor Cells, Cultured; Tyrphostins

2010
Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer.
    British journal of cancer, 2011, Apr-26, Volume: 104, Issue:9

    Topics: Animals; Apoptosis; Benzimidazoles; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Down-Regulation; Flow Cytometry; Fluorescent Dyes; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Gene Silencing; Immunohistochemistry; Lung Neoplasms; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Neoplastic Stem Cells; Octamer Transcription Factor-3; Receptors, Notch; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Signal Transduction; SOXB1 Transcription Factors; Up-Regulation; Wnt Proteins

2011